Grant of Options

Collagen Solutions Plc

(the "Company" or the "Group")

Grant of Option

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, is pleased to announce that it has today granted an option to Gillian Black, Chief Financial Officer, over up to 1,000,000 new ordinary shares of one penny each in the Company ("Ordinary Shares") pursuant to the terms of the EMI Share Option Scheme ("Option") exercisable at a price of 7.75p.

The Option will become exercisable from 1 January 2017 subject to Ms Black remaining in employment with the Company (or any other member of the Company's Group) and the achievement of either of the following two targets:

1) the market value of an Ordinary Share being equal to or greater than 27p on any date after the date of grant; and

2) the Company's earnings per share in any financial year which ends after the date of grant being equal to or greater than 1p.

Following the grant of the Option, the total number of options outstanding over Ordinary Shares is 5,938,349 equivalent to 9.30% of the Company's existing issued share capital.

Enquiries: